(Q50976831)
Statements
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO (English)
1 reference
1 reference
1 reference
John R Zalcberg
Lillian L Siu
1 reference
Jeremy D Shapiro
1 reference
Derek J Jonker
1 reference
Chris S Karapetis
1 reference
John Simes
1 reference
Felix Couture
1 reference
Malcolm J Moore
1 reference
Jehan Siddiqui
1 reference
Louise M Nott
1 reference
Danielle Charpentier
1 reference
Winston Liauw
1 reference
Michael B Sawyer
1 reference
Nadine M Magoski
1 reference
Andrew Haydon
1 reference
Ian Walters
1 reference
Dongsheng Tu
1 reference
Chris J O'Callaghan
1 reference
20 May 2013
1 reference
31
1 reference
19
1 reference
2477-2484
1 reference